Executive function in women post-menopause

AURORA, Colo. (March 26, 2020) – Assessing adverse childhood experiences and current anxiety and depression symptoms may help ease cognitive distress in women who have undergone a surgical menopause for cancer risk-reduction, or RRSO, according to a new study published in Menopause. Researchers, including Dr. Neill Epperson of the University of Colorado Anschutz Medical Campus,…

Texas Biomed accelerates multi-species study to identify COVID-19 animal model

San Antonio, Texas (March 26, 2020) – Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19). This study expands on a previously launched study to validate a baboon animal model for SARS-CoV-2, the…

Mount Sinai researchers unveil mechanisms to prevent Crohn’s disease

(New York, NY – March 26, 2020) – In a series of four studies published today in Gastroenterology, a journal of the American Gastroenterological Association, Mount Sinai inflammatory bowel disease (IBD) researchers, describe the identification of predictive tools and a new understanding of environmental factors that trigger IBD. “Early identification of individuals at high…

FDA approves ozanimod, a drug invented at Scripps Research, for multiple sclerosis

LA JOLLA, CA — The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn’s disease. In patient studies supporting ozanimod’s…